The 25 most influential people in biopharma in 2015
Every year, FierceBiotech compiles a list of the 25 most influential people in biopharma. These people are not only noteworthy leaders but are forcing this business to change for the better in fundamental ways.
- Bill Ackman – Pershing Square Capital Management
- Noubar Afeyan – Flagship Ventures
- Hans Bishop – Juno Therapeutics
- Dr. Robert Califf – FDA
- Andrew Conrad – Google Life Sciences
- Jennifer Doudna, Emmanuelle Charpentier – Caribou Biosciences, CRISPR Therapeutics
- Bob Duggan – Pharmacyclics
- David Epstein – Novartis
- George Freeman – U.K. Parliament
- Bob Hugin – Celgene
- Rajiv Kaul – Fidelity Investments
- Nick Leschly – bluebird bio
- Jacob Lew – U.S. Treasury Secretary
- Ge Li – WuXi PharmaTech
- John Martin – Gilead Sciences
- Steve Miller – Express Scripts
- David Mott – New Enterprise Associates
- Flemming Ornskov – Shire
- Brent Saunders – Actavis
- David Schenkein – Agios Pharmaceuticals
- Dilip Shanghvi – Sun Pharmaceutical
- Dr. Patrick Soon-Shiong – NantWorks
- Serge Weinberg – Sanofi
- Neil Woodford – Patient Capital Trust
